IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced that it has entered into a lease agreement with the Industrial Development Agency (IDA) of Ireland for a new manufacturing plant in Athlone, Ireland. This will be Aerie’s first manufacturing plant, expected to produce
Vision symptoms following concussion limit a child’s ability to return to the classroom
A comprehensive vision assessment should be part of return-to-learn protocols to help determine when children are ready to return to the classroom following concussions – particularly in children…
VIDEO: Measure, treat, track, fix: A four-step approach to successful toric IOL outcomes
At OSN New York, Denise M. Visco, MD, outlines her four-step approach to successful toric IOL outcomes: measuring, marking, tracking and fixing. Taking steps to ensure accurate measurements, choosing an appropriate nomogram and marking method, tracking…
VIDEO: Measure, treat, track, fix: A four-step approach to successful toric IOL outcomes
At OSN New York, Denise M. Visco, MD, outlines her four-step approach to successful toric IOL outcomes: measuring, marking, tracking and fixing. Taking steps to ensure accurate measurements, choosing an appropriate nomogram and marking method, tracking…
VIDEO: Better cataract surgery outcomes breed greater patient expectations
At OSN New York, Mitchell P. Weikert, MD, recalls two-and-a-half decades of progress in cataract surgery, including enhanced technologies, new techniques and a widening array of IOLs. As surgical outcomes have improved, so, too, have patient expectatio…
FDA Clears Ranibizumab for Myopic Choroidal Neovascularization
Ranibizumab becomes the first FDA-approved anti-vascular endothelial growth factor therapy for mCNV. FDA Approvals